About the webinar:
This two-part webinar series with Professor Lars Bode delves into the fascinating world of Human Milk Oligosaccharides – complex sugars and the third most abundant component of human milk after lactose and lipids. In part two, Professor Bode explores how and why HMOs are driving innovation that will revolutionize infant health beyond standardized nutrition. Be sure to attend part one of this webinar series or watch the recording before viewing part two.
About the speaker:
Dr. Lars Bode is Professor of Pediatrics in the Division of Neonatology and the Division of Gastroenterology, Hepatology and Nutrition, the Larsson-Rosenquist Chair of Collaborative Human Milk Research, and Director of the Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence (MOMI CORE) at the University of California, San Diego.
Dr. Bode has been working on human milk oligosaccharides (HMOs) for over 20 years. He received both his Master of Science and PhD degree in Nutritional Sciences from the University Giessen, Germany, and completed a pre-doctoral fellowship at the Institute of Child Health, University College London, United Kingdom. Following a postdoctoral fellowship at the Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California, Dr. Bode joined the University of California, San Diego, where he is leading a research program dedicated to investigating HMO biosynthesis and functions with potential benefits for infant health and development.
Dr. Bode has published over 120 peer-reviewed articles on HMOs, including the 2012 review “Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama”, which has become the most cited research article in the field of HMOs. In 2020, Dr. Bode ranked in the top 2% of most cited scientists in the world in the category “Nutrition and Dietetics”.
US dietitians: 1.0 CE from CDR. CPD/CEU hours are applicable for Australia and New Zealand dietitians. Check your local country requirements to see if you can claim for continuing education.